Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 25(11): 2064-2073, 2019 11.
Article in English | MEDLINE | ID: mdl-31625835

ABSTRACT

West Nile Virus (WNV) can result in clinically severe neurologic disease. There is no treatment for WNV infection, but administration of anti-WNV polyclonal human antibody has demonstrated efficacy in animal models. We compared Omr-IgG-am, an immunoglobulin product with high titers of anti-WNV antibody, with intravenous immunoglobulin (IVIG) and normal saline to assess safety and efficacy in patients with WNV neuroinvasive disease as part of a phase I/II, randomized, double-blind, multicenter study in North America. During 2003-2006, a total of 62 hospitalized patients were randomized to receive Omr-IgG-am, standard IVIG, or normal saline (3:1:1). The primary endpoint was medication safety. Secondary endpoints were morbidity and mortality, measured using 4 standardized assessments of cognitive and functional status. The death rate in the study population was 12.9%. No significant differences were found between groups receiving Omr-IgG-am compared with IVIG or saline for either the safety or efficacy endpoints.


Subject(s)
Central Nervous System Viral Diseases/drug therapy , Central Nervous System Viral Diseases/virology , Immunoglobulin G/therapeutic use , Immunoglobulins, Intravenous/therapeutic use , West Nile Fever/drug therapy , West Nile Fever/virology , West Nile virus , Adult , Aged , Antibodies, Neutralizing/administration & dosage , Antibodies, Neutralizing/immunology , Antibodies, Viral/administration & dosage , Antibodies, Viral/immunology , Central Nervous System Viral Diseases/immunology , Female , Humans , Immunoglobulin G/administration & dosage , Immunoglobulins, Intravenous/administration & dosage , Male , Middle Aged , Treatment Outcome , West Nile Fever/immunology , West Nile virus/immunology
3.
Dent Mater ; 29(10): 1026-33, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23937867

ABSTRACT

OBJECTIVES: To test the null hypothesis that polymerization-induced stress was not influenced by cavity dimensions and geometries. METHODS: Four experimental groups, with different C-factors and specimen volumes were defined using bottom-less glass disks (height: 1 or 2mm) with a central hole 3 or 6mm in diameter, and 3mm wall thickness. Another four groups were created by bonding a glass plate to the bottom of the disks. Additionally, disks with 2-mm height, 3mm in cavity diameter, and 4.5-mm thick walls were prepared. Vickers indents (9.8N, 20s) were made at the top surface at 600µm from the cavity margin. The lengths of the indentation diagonal and the corner cracks parallel to the cavity margin were measured. Ten minutes after restoration (Majesty Esthetic, Kuraray), cracks were re-measured. Stresses at the indent site were calculated based on glass fracture toughness and increase in crack length. Data were subjected to ANOVA/Tukey or Kruskal-Wallis/Mann-Whitney tests (alpha: 5%, n=8). Finite element analysis (FEA) was used to estimate stress at the interface and the effective structural rigidity of the substrate. RESULTS: Overall, for experimental and FEA results, cavities developed higher stress than bottom-less disks. Increasing wall thickness did not affect stress. When similar geometries and C-factors were compared, higher volumes developed higher stress and had greater incidence of margin cracking. CLINICAL SIGNIFICANCE: C-factor is a suitable predictor for polymerization stress in low compliance environments, particularly due to its simplicity. However, the influence of cavity size cannot be disregarded especially for the development of marginal cracking. The interaction between size, geometry and stiffness is likely to become more complex according to the complexity of the cavity shape.


Subject(s)
Finite Element Analysis , Polymerization , Stress, Mechanical , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...